Molecular Testing Strategies and Evaluation of Assay Performance

Join the Association for Molecular Pathology for a live webinar at 4 pm ET on October 27, during which Katherine B. Geiersbach and Shuko Harada will discuss molecular testing strategies for HR+ HER2- metastatic breast cancer and how to evaluate assay performance in molecular laboratories. A series of case examples and clinical scenarios will be presented to highlight core concepts in laboratory testing for ESR1, PIK3CA, AKT1, and PTEN mutations in breast cancer. 

This is part two in a three-part series about molecular genetic testing methods and current best practices for HR+/HER2- breast cancer.

Register for the webinar: https://educate.amp.org/local/catalog/view/product.php?productid=577